Horizon Therapeutics Public Limited Company Earning Date (HZNP)

USA |NASDAQ |USD

HZNP Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 $1.42 - $1.62
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 $965.99M - $832.55M

Horizon Therapeutics Public Limited Company's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

HZNP Earnings Date & History Chart

HZNP Earnings & Revenue Forecast

HZNP Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 11 $1.42 $1.27 $1.56
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 13 $5.93 $5.55 $6.91
Dec 2023 14 $7.30 $6.63 $8.61

HZNP Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 0 / 1 $1.42 $1.40 $1.51
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 1 $5.93 $5.87 $6.17
Dec 2023 1 / 0 $7.25 $7.33 $7.47

HZNP Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 10 $965.99M $920.72M $1.01B
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 13 $3.98B $3.92B $4.07B
Dec 2023 14 $4.60B $4.33B $4.91B

HZNP Earnings Date & Revenue History

HZNP Earnings History

|
Show More
Show More

HZNP Revenue History

|
Show More
Show More

Horizon Therapeutics Public Limited Company Next Earnings Date & Report

HZNP Next Earnings Date & Report Preview: Jun 2022 (FQ)

HZNP's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Horizon Therapeutics Public Limited Company's next quarterly earnings is $1.42, with a low EPS estimation of $1.27, and a high estimation of $1.56.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $1.42, the last 2 month trend is $1.40, and the 3 month trend is $1.51.

Based on analysts, the average revenue estimation is $965.99M, with a low revenue estimation of $920.72M, and a high estimation of $1.01B.

Horizon Therapeutics Public Limited Company Previous Earnings Dates & Reports

HZNP Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Horizon Therapeutics Public Limited Company's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

HZNP Previous Earnings Date & Report Recap: Dec 2021 (FY)

Horizon Therapeutics Public Limited Company's previous annual earnings date was Mar 1, 2022 for its fiscal year ended Dec 31, 2021.

HZNP's earnings per share (EPS) was $4.81, beating the consensus analysts forecast of $4.65 by 3.44% , and higher than the previous year's EPS (Dec 2020) by 25.92%.

Revenues were $3.23B, better than the forecast of $3.20B by 0.83%, and up by 46.63% from previous year's revenue.

The company reported a net income of $534.49M, 37.12% higher than the previous year.

Horizon Therapeutics Public Limited Company reported a free cash flow of $909.10M for its fiscal year, compared to $355.84M a year ago.

The company ended the fiscal year with $2.57B in total debt, an increase of 156.26% compared to the previous year.